Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA

By Karalis Vangelis   Symillides Mira   Macheras Panos  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1066-1077

Springer Publishing Company

Access to resources Recommend Favorite

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

By Lobenberg R.   Amidon G.L.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 3-12

Elsevier

Access to resources Recommend Favorite

Bioequivalence testing by statistical shape analysis

By Pereira Luis  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 4, 2007-08 ,pp. : 451-484

Springer Publishing Company

Access to resources Recommend Favorite

Levothyroxine: therapeutic use and regulatory issues related to bioequivalence

By Wartofsky Leonard  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 727-732

Informa Healthcare

Access to resources Recommend Favorite

Investigation and Need of Bioequivalence Study: Methodology and Regulatory Requirement

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 2, 2014-08 ,pp. : 93-106

Bentham Science Publishers

Access to resources Recommend Favorite